Analyst Price Target is $16.67
▲ +954.85% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Calidi Biotherapeutics in the last 3 months. The average price target is $16.67, with a high forecast of $20.00 and a low forecast of $10.00. The average price target represents a 954.85% upside from the last price of $1.58.
Current Consensus is
Buy
The current consensus among 3 polled investment analysts is to buy stock in Calidi Biotherapeutics. This Buy consensus rating has held steady for over two years.